1. Home
  2. VRTX vs SBUX Comparison

VRTX vs SBUX Comparison

Compare VRTX & SBUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated

N/A

Current Price

$517.10

Market Cap

135.6B

Sector

Technology

ML Signal

N/A

Logo Starbucks Corporation

SBUX

Starbucks Corporation

N/A

Current Price

$103.54

Market Cap

122.3B

ML Signal

N/A

Company Overview

Basic Information
Metric
VRTX
SBUX
Founded
1989
1971
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Restaurants
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
135.6B
122.3B
IPO Year
2007
1994

Fundamental Metrics

Financial Performance
Metric
VRTX
SBUX
Price
$517.10
$103.54
Analyst Decision
Buy
Buy
Analyst Count
32
36
Target Price
★ $595.36
$111.07
AVG Volume (30 Days)
1.3M
★ 7.1M
Earning Date
11-02-2026
10-29-2026
Dividend Yield
N/A
★ 2.41%
EPS Growth
★ 836.54
35.58
EPS
★ 10.90
2.21
Revenue
$2,488,652,000.00
★ $37,910,600,000.00
Revenue This Year
$10.46
N/A
Revenue Next Year
$10.53
$3.80
P/E Ratio
$47.77
★ $47.09
Revenue Growth
★ 46.20
1.95
52 Week Low
$412.27
$81.97
52 Week High
$568.67
$111.50

Technical Indicators

Market Signals
Indicator
VRTX
SBUX
Relative Strength Index (RSI) 41.75 47.30
Support Level $493.75 $101.95
Resistance Level $536.58 $103.69
Average True Range (ATR) 15.90 3.22
MACD -3.73 -0.65
Stochastic Oscillator 4.74 7.14

Price Performance

Historical Comparison
VRTX
SBUX

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex is focused on diversifying its portfolio through Casgevy (gene-editing therapy for beta thalassemia and sickle-cell disease), Journavx (non-opioid pain drug for moderate-to-severe acute pain), and Palsonify (for acromegaly). Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases, cell therapies to deliver a functional cure for type 1 diabetes, povetacicept (for IgA nephropathy).

About SBUX Starbucks Corporation

Starbucks stands out as the world's largest and most recognizable coffee brand, powered by ultracustomizable beverages in-store and a sweeping footprint of nearly 41,000 cafes in over 80 countries. About 52% are company-operated, with the balance run by licensees. The company operates roasteries and sells across its North America (74% of revenue as of the end of fiscal 2025), international (21%), and channel development (5%) segments. The brand collects revenue from company-operated stores, licensee royalties, equipment and product sales, retail ready-to-drink beverages, and packaged coffee.

Share on Social Networks: